Inhibitor
Cat.No. | Name | Information |
---|---|---|
M9837 | Thalidomide-O-amido-C4-NH2 (TFA) | Thalidomide-O-amido-C4-NH2 TFA is a synthesized E3 ligase ligand-linker conjugate that incorporates the Thalidomide based cereblon ligand and a linker. |
M9836 | Pomalidomide-PEG4-C-COOH | Pomalidomide-PEG4-C-COOH (E3 Ligase Ligand-Linker Conjugates 1) is a synthesized E3 ligase ligand-linker conjugate that incorporates the Pomalidomide based cereblon ligand and 4-unit PEG linker. |
M43410 | Cereblon inhibitor 2 | Cereblon inhibitor 2 is a Cereblon inhibitor useful in solid tumor research, especially breast cancer. |
M43409 | Pomalidomide-C7-NH2 hydrochloride | Pomalidomide-C7-NH2 (Pomalidomide 4'-alkylC7-amine) hydrochloride is an E3 ligase ligand-linker conjugate. |
M31273 | Thalidomide-NH-PEG2-C2-NH-Boc | Thalidomide-NH-PEG2-C2-NH-Boc is a synthesized E3 ligase ligand-linker conjugate that incorporates the Thalidomide based cereblon ligand and a PEG linker used for dBRD9 synthesis. dBRD9 is a selective BRD9 probe PROTAC degrader for the study of BAF complex biology. |
M31272 | Thalidomide-C2-amido-C2-COOH | Thalidomide-C2-amido-C2-COOH incorporates a CRBN ligand for the E3 ubiquitin ligase, and a linker. Thalidomide-C2-amido-C2-COOH can be used to design PROTAC CDK2/9 Degrader-1. |
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.